Formulation and Evaluation of Luliconazole Nanosponge Gel Using Experimental Design

被引:0
作者
Noothi, Sadhana [1 ]
Malothu, Narender [1 ]
Areti, Anka Rao [1 ]
Pulavarthy, Vishnu [2 ]
机构
[1] Koneru Lakshmaiah Educ Fdn, KL Coll Pharm, Vaddeswaram, AP, India
[2] B V Raju Inst Technol, Dept Pharmaceut Engn, Medak, Telangana, India
来源
INDONESIAN JOURNAL OF PHARMACY | 2024年 / 35卷 / 02期
关键词
Luliconazole; Carbopol; 934; Skin permeability; Central Composite Design; DRUG-DELIVERY SYSTEM; IN-VITRO; OPTIMIZATION; RELEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Different approaches are being used for the topical application of antifungal drugs. Luliconazole (LUL) is one of the antifungal medications that are being used for the treatment of various superficial infections. The poor permeability of LUL is regarded to be a factor for its reduced efficacy. Hence, the current study aimed to develop a nanosponge hydrogel to improve dermal availability and permeability. A set of nanosponge formulations (L1 -L17) were designed with the help of central composite design (Design Expert 13, state ease Inc., Minneapolis, MN, USA). L1 -L17 was prepared by using the emulsion solvent evaporation technique. The nanosponges were characterized for drug-excipient compatibility (FTIR, P-XRD, and DSC), and particle size, polydispersibility index, zeta potential, entrapment efficiency (%EE), and in vitro drug release; further optimized. The optimized nanosponge formulation (OLF) was taken to produce six hydrogels (LF1-LF6) of LUL by varied proportions of the gelling agent. In this process, initially, the gel was constituted with Carbopol 934/ sodium CMC/HPMC. Later, hydrogel texture was evaluated for its viscosity, swelling, and membrane permeability, followed by in vitro drug release and antifungal efficacy. The nanosponge formulations (L1 -L17) had an average particle size of 109 +/- 0.45 to 386 +/- 0.34 nm, entrapment efficiency of 35.45 +/- 0.46- 89.65 +/- 0.37 % with 84.67 +/- 0.5499.65 +/- 0.48 % of drug release for 6 h. The formulation OLF was predicted with better particle size, %EE, and drug release responses at 378 +/- 0.25 nm, 84.65 +/- 0.45%, and 96.18 +/- 0.54% for 4 h. Out of six formulated nanosponge gels (LF1-LF6), LF2 showed an optimal viscosity (25.69 +/- 0.45 pa.S), pH (6.87 +/- 0.56) and % drug release (80.65 +/- 0.64%) in 4 h. Drug release was governed by non-fickian diffusion mechanisms and zero -order. This nanosponge hydrogel was found stable and had a high permeation rate with better retention, which can be compelling enough in topical applications.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 33 条
[1]   Nanosponge-based hydrogel preparation of fluconazole for improved topical delivery [J].
Abbas, Nasir ;
Parveen, Kousar ;
Hussain, Amjad ;
Latif, Sumera ;
Zaman, Shaiq Uz ;
Shah, Pervaiz Akhtar ;
Ahsan, Muhammad .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (02) :215-222
[2]  
Abdullah A, 2022, INDONES J PHARM, V33, P395
[3]  
Aditya KG., 2021, Topical antifungal agent's comprehensive dermatologic drug therapy fourth edition, P480
[4]  
Aggarwal Geeta, 2016, Pharm Nanotechnol, V4, P213, DOI 10.2174/2211738504666160804154213
[5]   Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection [J].
Ahmed, Mohammed Muqtader ;
Fatima, Farhat ;
Anwer, Md Khalid ;
Ibnouf, Elmutasim Osman ;
Abul Kalam, Mohd ;
Alshamsan, Aws ;
Aldawsari, Mohammed F. ;
Alalaiwe, Ahmed ;
Ansari, Mohammad Javed .
SAUDI PHARMACEUTICAL JOURNAL, 2021, 29 (05) :467-477
[6]   Development, Optimization, and Evaluation of Luliconazole Nanoemulgel for the Treatment of Fungal Infection [J].
Alhakamy, Nabil A. ;
Md, Shadab ;
Alam, Md Shoaib ;
Shaik, Rasheed A. ;
Ahmad, Javed ;
Ahmad, Abrar ;
Kutbi, Hussam, I ;
Noor, Ahmad O. ;
Bagalagel, Alaa ;
Bannan, Douha F. ;
Gorain, Bapi ;
Sivakumar, Ponnurengam Malliappan .
JOURNAL OF CHEMISTRY, 2021, 2021
[7]   Design and optimization of topical terbinafine hydrochloride nanosponges: Application of full factorial design, in vitro and in vivo evaluation [J].
Amer, Reham, I ;
El-Osaily, Ghada H. ;
Gad, Sameh S. .
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2020, 11 (01) :13-19
[8]  
[Anonymous], 2018, INT J APP PHARM, DOI DOI 10.22159/IJAP.2018V10I5.27506
[9]  
Aydar A.Y., 2018, UTILIZATION RESPONSE, P157, DOI DOI 10.5772/INTECHOPEN.73690
[10]   Central Composite Design Aided Formulation Development and Optimization of Clarythromycin Extended-Release Tablets [J].
Chinthaginjala, Haranath ;
Ahad, Hindustan Abdul ;
Bhargav, Eranti ;
Pradeepkumar, Bhupalam .
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021, 55 (02) :395-406